Mainstream Starts to Cover: NBC Affiliate Covers COVID-19 Vaccine Injured, Cautiously

Mainstream media has started to cover the topic of COVID-19 vaccine injury. Most recently, KARE 11 in Minneapolis thanks to Craig Norkus, a 22-year photojournalist at the media who became ill after receiving the COVID-19 jab in November 2022.

While the NBC affiliate for the Twin Cities area first acknowledges that the overall general safety of the COVID-19 vaccines has been established, this doesn’t necessarily mean that a “small group of Minnesotans claiming vaccine injury” aren’t hurting, in some cases, severely due to rare but real COVID-19 vaccine injuries.

Another TrialSite subscriber and vaccine-injured person sent the story to TrialSite, noting the NBC affiliate loaded the content with lots of accompanying vaccine-friendly information but points out that the local media finally covered the topic of COVID-19 vaccine injury.

Pointing out that recent studies evidence an overall safety profile, some questions remain unanswered. To date, KARE 11 states that no study has been able to prove that mRNA vaccines can induce neurological problems, the reality is that numerous such problems can and do ensue after vaccination.

Patient advocacy group React19, a TrialSite partner, established the Scientific Publications Directory for example. In this repository set up via a collaborative effort with TrialSite’s support, React19 now maintains 3,580 peer-reviewed studies (mostly case series) tracking various adverse event incidents post-COVID-19 vaccination.

How many of the studies involve neurological conditions? 656 studies cover some form of neurological condition associated with COVID-19 vaccination. This does not mean that each one of these studies prove that the vaccine caused the condition.

In fact, most of the studies in the online directory are case series, meaning a type of medical research design that involves the detailed examination of a small group of individuals (or just one patient) who share common characteristics or experiences. In a case series, researchers typically report on the clinical features, treatment, and outcomes of a series of patients with similar conditions or who underwent similar interventions. However, unlike a randomized controlled trial, these investigations are not designed to establish causation.

Unfortunately, the NBC affiliate doesn’t cite the React19 database, although they should. The media does refer to the recent study tracked by TrialSite involving the recent study from the National Academy of Sciences, Engineering and Medicine finding that only one adverse event with a proven link to the Pfizer and Moderna shots-- myocarditis—inflammation of the heart. The experts in the study determined the two mRNA vaccines do not cause Guillain-Barré syndrome, Bell’s palsy, thrombosis with thrombocytopenia syndrome (TTS) or heart attack. Researchers determined there's not enough evidence to accept or deny a link to any other neurological issues studied. Although, it’s clear from the React19 publication directory that incidence of GBS for example as well as Bell’s palsy are associated with these vaccines.

According to Norkus, who was a key force in getting this coverage of the COVID-19 vaccine injured after receiving the COVID-19 vaccine, “I felt like I was dying,” said Norkus. “I was lost, looking for answers, and no one had any.”

The injury presented just two days following a booster dose of the Pfizer COVID-19 vaccine. The photojournalist started suffering head and body aches, severe exhaustion, and confusion, along with cool and hot tingling in his fingers and legs.

As reported by Chris Hrapsky blood tests revealed his immune system was under attack, but five separate specialty doctors could not explain the source of his symptoms.

Yet by April last year, an osteopathic doctor diagnosed Norkus with immunosuppression and small fiber neuropathy. And Norkus’ physician now believes that Norkus’ conditions were triggered by the vaccine.

While the local media claims no study can prove an mRNA connection to Bell’s palsy, the React19 online database includes 45 peer-reviewed studies involving COVID-19 vaccination and Bell’s palsy. See the link.

TrialSite’s Brandon Bushong recently interviewed vaccine injury activist Wayne Rohde, author of “The Vaccine Court 2.0 Revised: The Dark Truth of America’s Vaccine Injury Compensation Program” who elaborates on all the ways bias impacts the system, to the detriment of those injured and in urgent need of care.

https://www.trialsitenews.com/a/mainstream-starts-to-cover-nbc-affiliate-covers-vaccine-injured-cautiously-296e7c90

**************************************************

COVID-19 mRNA Vaccines Linked to Cutaneous [skin] Adverse Events—Most Non-Significant, However, Severe in Rare Cases

Dermatologist from the Department of Dermatology, Kagoshima City Hospital and University Graduate School of Medical and Dental Sciences Kagoshima, Japan investigate cutaneous adverse events (AEs) manifesting after COVID-19 vaccination.

Frequently described, the investigators led by Atsunori Baba M.D., and colleagues report the need for a larger case series and literature review and hence this specific study. Calling out for the urgent need for an extensive investigation of new cases and previous reports to better capture the unfolding evidence concerning post-COVID-19 immunization cutaneous AEs, the team sought to analyze patients with cutaneous AEs after COVID-19 vaccination in their specific hospital located in deep southern Japan on Kyushu island.

The team of physicians also reviewed studies of cutaneous AEs. Analyzing post-COVID-19 vaccination cutaneous AEs in the Kagoshima City Hospital department, the Japanese Registry, and previous literature, the investigators also enrolled 30 patients with cutaneous post-vaccination AEs in the department over 2 years (April 1, 2021, to March 31, 2023). Confirming cases registered in the Ministry of Health, Labor, and Welfare COVID-19 vaccine side effect reporting system (February 17, 2021–March 12, 2023), the study team reports 587 retrieved records, plus 93 articles were included for data extraction.

Dr. Atsunori Baba and colleagues report on the identification of a total of 28 non-injection-site cutaneous AEs and two injection-site AEs. Six (20.0%) patients developed new-onset erythematous eruptions, and five (16.7%) patients developed urticaria. Pruritic eruption, eczema, shingles, and sweating symptoms have also been reported.

Published in the peer-reviewed Journal of Dermatology, Atsunori Baba and colleagues point out that in previous studies on non-injection-site cutaneous AEs, individuals who received the BNT162b2 vaccine were older than those who received mRNA-1273 (P < 0.01).

Cutaneous AEs were mostly nonsignificant and self-limiting reactions; but the study authors report on rare, severe, or life-threatening AEs also linked to COVID-19 vaccination.

The findings lead the authors of this study to conclude that “Physicians should be aware of the various possible cutaneous AEs associated with the COVID-19 vaccination.”

https://www.trialsitenews.com/a/covid-19-mrna-vaccines-linked-to-cutaneous-adverse-eventsmost-non-significant-however-severe-in-rare-cases-a6fa4ec5

***********************************************

Western Vaccines Outperform the Chinese with Significant More Protection Against Breakthrough Infection

A team of pharmacy researchers from University of Cyberjava in Persiaran Bestari, Selangor Malaysia and Serdang Hospital conducted a retrospective cohort study at a multispecialty tertiary hospital in Selangor, including 200 fully adult vaccinated patients, with confirmed SARS-CoV-2 infection, admitted from September 2021 to February 2022.

Participants were selected by simple random sampling. Infection severity was categorized as CAT 2–3 (mild–moderate) and 4–5 (severe–critical). Vaccinated with the Pfizer-BioNTech mRNA vaccine known as BNT162b2, the Malaysian team sought to learn more about mRNA vaccine performance. What were the clinical outcomes (time to breakthrough infection, intensive care unit [ICU] admission, and in-hospital mortality) of hospitalized patients with SARS-CoV-2 breakthrough infection concerning the Pfizer-BioNTech jab?

With results published in Heliyon, the authors report:
“The time to breakthrough infection was significantly longer for BNT162B2 recipients (128.47 ± 46.21 days) compared to CoronaVac (94.09 ± 48.71 days; P = 0.001) and ChAdOx1-S recipients (90.80 ± 37.59 days; P = 0.019).”

Also, the authors reported no associations involving SARS-CoV-2-related ICU admission, mortality, and the vaccines.

Based on a statistical multivariable analysis, the study’s authors point to the following as significant predictors of severity:

Vaccine type
Variant of concern
Ethnicity
Hypertension

Evidencing superior performance for the Western COVID-19 vaccines, “BNT162b2 and ChAdOx1-S recipients had significantly (81% and 74%, respectively) lower odds of CAT 4–5 infection compared to CoronaVac recipients.” The latter was developed in China.

Interestingly, from an ethnicity perspective, Indian patients faced a (83%) lower chance of CAT 4–5 infection compared to Malay patients.

For breakthrough infections, the Delta surge was more dangerous than Omicron. Patients with breakthrough infections during the latter period had a significantly (58%) lower risk of CAT 4–5 compared to those in the former (Delta). The CAT 4–5 risk was significantly (nearly threefold) higher in hypertensive patients.

https://www.trialsitenews.com/a/western-vaccines-outperform-the-chinese-with-significant-more-protection-against-breakthrough-infection-d69239f6

*************************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com (TONGUE-TIED)

https://immigwatch.blogspot.com (IMMIGRATION WATCH)

https://awesternheart.blogspot.com (THE PSYCHOLOGIST)

http://jonjayray.com/blogall.html More blogs

*********************************************************